Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.50 |
| ▸ | NOS1 | P29475 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12122146 | 1.00 | NOS3 (0.50) | NOS3NOS1MEN1MAPTKMT2A | |
| SCHEMBL28038600 | 1.00 | NOS3 (0.50) | NOS3NOS1MEN1MAPTKMT2A | |
| SCHEMBL6488472 | 0.93 | ALDH1A1 (0.52) | NOS3NOS1MEN1MAPTKMT2A | |
| SCHEMBL9331190 | 0.85 | NOS3 (0.54) | NOS3NOS1MEN1MAPTKMT2A | |
| SCHEMBL40655 | 0.85 | NOS3 (0.54) | NOS3NOS1MEN1MAPTKMT2A | |
| SCHEMBL9331652 | 0.85 | NOS3 (0.54) | NOS3NOS1MEN1MAPTKMT2A | |
| SCHEMBL9331061 | 0.85 | NOS3 (0.54) | NOS3NOS1MEN1MAPTKMT2A | |
| SCHEMBL114216 | 0.82 | UGT2B7 (0.52) | NOS3NOS1ALDH1A1HIF1AHTT | |
| SCHEMBL5955 | 0.79 | MAPT (0.53) | NOS3NOS1MEN1MAPTKMT2A | |
| SCHEMBL18388220 | 0.79 | KDM4E (0.43) | MEN1MAPTKMT2AALDH1A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 857 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3911795-B1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2025-10-01 | — | — | EP | claimed |
| WO-2025067404-A1 | ENDOGLYCOSIDASE S2 MUTANT, PREPARATION METHOD THEREFOR AND USE THEREOF IN ANTIBODY GLYCOSYLATION MODIFICATION | 上海糖岭生物医药有限责任公司 | 2025-04-03 | — | — | WO | claimed |
| CN-119709701-A | Endoglycosidase S2 mutant, preparation method thereof and application thereof in antibody glycosylation modification | 上海糖岭生物医药有限责任公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119456051-B | Preparation method of nano metal passivating agent | 淄博凯美可工贸有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119456051-A | Preparation method of nano metal passivating agent | 淄博凯美可工贸有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118638027-A | Anthraquinone parent nucleus structure compound and preparation method and application thereof | 广西医科大学 | 2024-09-13 | — | — | CN | claimed |
| CN-117334944-B | Composite protective coating for metal bipolar plate and preparation method thereof | 广东思达氢能科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118125781-B | Light heat-insulating material prepared from waste incineration fly ash and preparation method thereof | 湖南国发控股有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118007442-B | Unidirectional moisture-conducting fabric and preparation method thereof | 广东云蝶园内衣科技有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118255954-A | High-temperature-resistant salt-resistant filtrate reducer, preparation method and application | 中石化石油工程技术服务有限公司 | 2024-06-28 | — | — | CN | claimed |
| EP-1799791-B1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2016-01-13 | — | — | EP | claimed |
| CN-105177070-A | Method for yeast production of (S)-aminophenyl ethanol | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2015-12-23 | — | — | CN | claimed |
| CN-101784540-B | Alcohols containing imide moieties and reactive oligomers prepared therefrom | NAT STARCH CHEM INVEST | 2013-12-25 | — | — | CN | claimed |
| CN-103232352-A | (R)-4-(2-(2-hydroxyl-2-phenylethylamino)-ethyl) tert-butyl phenylcarbamate | SUZHOU UUGENE BIOPHARMA CO LTD | 2013-08-07 | — | — | CN | claimed |
| US-7928245-B2 | Alcohols containing imide moieties and reactive oligomers prepared therefrom | HENKEL AG & CO. KGAA (DE) | 2011-04-19 | — | — | US | claimed |
| US-20100190998-A1 | Alcohols Containing Imide Moieties and Reactive Oligomers Prepared Therefrom | HENKEL AG & CO. KGAA (DE) | 2010-07-29 | — | — | US | claimed |
| CN-101784540-A | alcohols containing imide moieties and reactive oligomers prepared therefrom | NAT STARCH CHEM INVEST | 2010-07-21 | — | — | CN | claimed |
| EP-0623635-B1 | Amine-functionalized polyester | GEN ELECTRIC (US) | 2003-02-19 | — | — | EP | claimed |
| US-5384387-A | Amino acid or amino alcohol reacted into polymer | GENERAL ELECTRIC COMPANY (US) | 1995-01-24 | — | — | US | claimed |
| EP-0623635-A1 | Amine-functionalized polyester | GENERAL ELECTRIC COMPANY (US) | 1994-11-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190998-A1 | Alcohols Containing Imide Moieties and Reactive Oligomers Prepared Therefrom | ADH1C, ADH1A, ADH5 | NOS3 1056/4885NOS1 1133/4885MEN1 3306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.